Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin PREHAB for Vestibular Schwannoma
NCT02379754Phase 4Withdrawn
- Sponsor
- Lund University
- Start
- Jan 2015
- Primary completion
- Jun 2019
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of gentamicin in vestibular schwannoma (VS), sponsored by Lund University. Planned start Jan 2015; status: withdrawn.
02
Drugs
gentamicin
03
Conditions
vestibular schwannoma (VS)
Beyond the preview
Go deeper on NCT02379754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379754.